U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H13N5O3.H2O
Molecular Weight 269.2572
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2'-DEOXYADENOSINE MONOHYDRATE

SMILES

O.NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC=N1

InChI

InChIKey=WZJWHIMNXWKNTO-VWZUFWLJSA-N
InChI=1S/C10H13N5O3.H2O/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7;/h3-7,16-17H,1-2H2,(H2,11,12,13);1H2/t5-,6+,7+;/m0./s1

HIDE SMILES / InChI

Molecular Formula C10H13N5O3
Molecular Weight 251.2419
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

2′-Deoxyadenosine, a pair of deoxythymidine (T) in double-stranded DNA, is a substrate of adenosine deaminase. In case of absence of this enzyme, 2′-deoxyadenosine accumulates in T lymphocytes and kills these cells resulting in a genetic disorder known as adenosine deaminase severe combined immunodeficiency disease (ADA-SCID).

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P00813
Gene ID: 100.0
Gene Symbol: ADA
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Polymerase Bypass of N(6)-Deoxyadenosine Adducts Derived from Epoxide Metabolites of 1,3-Butadiene.
2015-07-20
Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity.
2014-01-06
Effects of substitutions at the 4' and 2 positions on the bioactivity of 4'-ethynyl-2-fluoro-2'-deoxyadenosine.
2013-12
Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors.
2011-01-13
A 13-Oxo-9,10-epoxytridecenoate phospholipid analogue of the genotoxic 4,5-epoxy-2E-decenal: detection in vivo, chemical synthesis, and adduction with DNA.
2010-03-15
Direct detection of 8-oxo-deoxyguanosine using UV resonance Raman spectroscopy.
2006-07-01
Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication.
2006
Characterization of glycine N-methyltransferase from rabbit liver.
2004-06
Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1.
2003-09-15
Selectivity of purine alkylation by a quinone methide. Kinetic or thermodynamic control?
2003-08-08
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1.
2002-09
5'-Esters of 2'-deoxyadenosine and 2-chloro-2'-deoxyadenosine with cell differentiation-provoking agents.
2002
Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.
2001-07
Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain.
2000-12-01
Phosphorylation of the anti-HIV compound (S,S)-isodideoxyadenosine by human recombinant deoxycytidine kinase.
2000-11-15
1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism.
1999-04
Determination of adenosine and deoxyadenosine in urine by high-performance liquid chromatography with column switching.
1998-11-20
Rapid radioassay for metabolites of adenosine and deoxyadenosine in erythrocytes.
1995-12-01
High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.
1993-04
Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
1992-01-22
Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools.
1989-09
Genetic analysis of deoxyadenosine toxicity in dividing human lymphoblasts.
1986
Analytical DNA flow cytometric analysis of deoxyadenosine toxicity in cultured human leukemic lymphoblasts.
1984-09
Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.
1984-09
Nucleotide levels and metabolism of adenosine and deoxyadenosine in intact erythrocytes deficient in adenosine deaminase.
1984
S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
1983-07
Adenosine and deoxyadenosine toxicity in colony assay systems for human T-lymphocytes, B-lymphocytes, and granulocytes.
1982
A comparison of the carcinogen-DNA adducts formed in rat liver in vivo after administration of single or multiple doses of N-methyl-4-aminoazobenzene.
1981-12
Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.
1980-11
Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.
1980-07
Antiviral, antimetabolic and antineoplastic activities of 2'- or 3'-amino or -azido-substituted deoxyribonucleosides.
1980-06-15
Altered deoxynucleoside triphosphate levels paralleling deoxyadenosine toxicity in adenosine deaminase inhibited human lymphocytes.
1980
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:13:30 GMT 2025
Edited
by admin
on Mon Mar 31 18:13:30 GMT 2025
Record UNII
F79D3BS9UH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ADENOSINE, 2'-DEOXY-, HYDRATE (1:1)
Preferred Name English
2'-DEOXYADENOSINE MONOHYDRATE
Systematic Name English
ADENOSINE, 2'-DEOXY-, MONOHYDRATE
Systematic Name English
Code System Code Type Description
FDA UNII
F79D3BS9UH
Created by admin on Mon Mar 31 18:13:30 GMT 2025 , Edited by admin on Mon Mar 31 18:13:30 GMT 2025
PRIMARY
EPA CompTox
DTXSID801036040
Created by admin on Mon Mar 31 18:13:30 GMT 2025 , Edited by admin on Mon Mar 31 18:13:30 GMT 2025
PRIMARY
CAS
16373-93-6
Created by admin on Mon Mar 31 18:13:30 GMT 2025 , Edited by admin on Mon Mar 31 18:13:30 GMT 2025
PRIMARY
PUBCHEM
9549172
Created by admin on Mon Mar 31 18:13:30 GMT 2025 , Edited by admin on Mon Mar 31 18:13:30 GMT 2025
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE